Dear Dermatoethicist: Medical Student Dermatology Rotations in the Context of COVID-19

Muzumdar S, Grant-Kels JM, Feng H.

Resumption of laser/IPL skin services post COVID-19 lockdown-British Medical Laser Association (BMLA) guidance document

Madan V.

[Chilblains in lockdown: an old acquaintance in the context of COVID-19]

Català Gonzalo A, Galván Casas C.

A case of erythema multiforme major in a patient with COVID 19: The role of corticosteroid treatment

Demirbaş A, Elmas ÖF, Atasoy M, Türsen Ü, Lotti T.

Acute acral cutaneous manifestations during the COVID-19 pandemic: a single center experience

García-Legaz Martínez M, Martínez-Doménech Á, Magdaleno-Tapial J, Valenzuela-Oñate C, Partarrieu-Mejías F, Lorca-Spröhnle J, Casanova-Esquembre A, Pérez-Ferriols A, Alegre-de Miquel V.

COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients

Pfaar O, Torres MJ, Akdis CA.

Recent outbreak of chilblain-like lesions is not directly related with SARS-CoV-2 infection

Rouanet J, Lang E, Beltzung F, Evrard B, Henquell C, Joulie I, D'Incan M.

Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature

Matar S, Oulès B, Sohier P, Chosidow O, Beylot-Barry M, Dupin N, Aractingi S.

COVID-19 effect on phototherapy treatment utilization in dermatology

Fisher S, Ziv M.

COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a PCR-negative patient

Santonja C, Heras F, Núñez L, Requena L.

Comment on: "To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients."

Fernandez-Nieto D, Ortega-Quijano D, Suarez-Valle A, Burgos-Blasco P, Jimenez-Cauhe J, Fernandez-Guarino M.

Cutaneous manifestations of SARS-CoV-2 infection: a clinical update

Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L.

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic

Herman A, Peeters C, Verroken A, Tromme I, Tennstedt D, Marot L, Dachelet C, Gruson D, Hermans C, Baeck M.

Cutaneous manifestations in hospitalized patients diagnosed as COVID-19

Askin O, Altunkalem RN, Altinisik DD, Uzuncakmak TK, Tursen U, Kutlubay Z.

Oral erosions and petechiae during SARS-CoV-2 infection

Ciccarese G, Drago F, Boatti M, Porro A, Muzic SI, Parodi A.

Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19

Trellu LT, Kaya G, Alberto C, Calame A, McKee T, Calmy A.

Inpatient Dermatology Consultations during Covid 19 Pandemic in a Tertiary Referral Center

Uzuncakmak TK, Bayazit S, Askin O, Engin B, Kutlubay Z.

COVID-19 in dermatology practice: getting back on track

Cembrano KAG, Ng JN, Rongrungruang Y, Auewarakul P, Goldman MP, Manuskiatti W.

Histopathological Study of a Broad Spectrum of Skin Dermatoses in Patients Affected or Highly Suspected of Infection by COVID-19 in the Northern Part of Italy: Analysis of the Many Faces of the Viral-Induced Skin Diseases in Previous and New Reported Cases

Gianotti R, Recalcati S, Fantini F, Riva C, Milani M, Dainese E, Boggio F.

Impact of the COVID-19 Pandemic on Immunomodulatory and Immunosuppressive Therapies in Dermatology: Patient and Physician Attitudes in Argentina

Zimman S, Cura MJ, Luna PC, Echeverría CM, Mazzuoccolo LD.

COVID-19 Supply Chain Considerations for Prescription Drugs in Dermatology

Egger A, Abrouk M, Brodsky M, Kirsner RS.

Outpatient Teledermatology Implementation During the COVID-19 Pandemic: Challenges and Lessons Learned

Farshchian M, Potts G, Kimyai-Asadi A, Mehregan D, Daveluy S.

Facial Abrikosoff tumour: The role of the dermatologist during COVID-19 pandemic

Orsini D, D'Arino A, Tedesco M, Cota C, Pigliacelli F, Assorgi C, Latini A, Cristaudo A, Morrone A.

Chilblain-like lesions during the COVID-19 pandemic: early or late sign?

Recalcati S, Fantini F.

Skin and COVID-19

Klejtman T.

Navigating Immunosuppression in a Pandemic: A Guide for the Dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists

Niaki OZ, Anadkat MJ, Chen ST, Fox LP, Harp J, Micheletti RG, Nambudiri VE, Pasieka HB, Shinohara MM, Rosenbach M, Merola JF.

Organization of biologic therapy during the COVID-19 pandemic based on example of Dermatology Clinic Centre of Postgraduate Medical Education in Warsaw

Dopytalska K, Mikucka-Wituszyńska A, Ciechanowicz P, Szczerba M, Szymańska E, Walecka I.

Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from authors

Galv√°n-Casas C, Catal√° A, Carretero Hern√°ndez G, Garcia-Doval I.

Psoriasis and COVID-19: a multifactorial consideration

Cohen JM, Perez-Chada LM, De Kouchkovsky D, Gehlhausen JR.

Clinical management of psoriasis patients during the COVID-19 pandemic

Chat VS, Uppal SK, Kearns DG, Wu JJ.

Can Users Search Trends Predict People Scares or Disease Breakout? An Examination of Infectious Skin Diseases in the United States

Obeidat R, Alsmadi I, Bani Bakr Q, Obeidat L.

Chilblain and Acral Purpuric Lesions in COVID-19

Wiwanitkit V.

Recommendations on Sun Exposure and Photoprotection Following Easing of the COVID-19 Pandemic Lockdown: Spanish Photobiology Group of the Spanish Academy of Dermatology and Venerology (AEDV)

Aguilera J, de Gálvez MV, Aguilera P, de Troya M, Gilaberte Y; del Grupo Español de Fotobiología de la AEDV.

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19

Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso.

Live-interactive teledermatology program in Taiwan: One-year experience serving a district hospital in rural Taitung County

Lee CH, Huang CC, Huang JT, Wang CC, Fan S, Wang PS, Lan KC.

International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries

Freeman EE, McMahon DE, Hruza GJ, Irvine AD, Spuls PI, Smith CH, Mahil SK, Castelo-Soccio L, Cordoro KM, Lara-Corrales I, Naik HB, Alhusayen R, Ingram JR, Feldman SR, Balogh EA, Kappelman MD, Wall D, Meah N, Sinclair R, Beylot-Barry M, Fitzgerald M, French LE, Lim HW, Griffiths CEM, Flohr C.

SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of 7 paediatric cases

Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A.

Dear Dermatoethicist:The Ethics of Charging Patients an Infection Control Fee in the Context of COVID-19

Muzumdar S, Grant-Kels JM, Feng H.

Unraveling the mystery of Covid-19 Cytokine storm: From skin to organ systems

Garg S, Garg M, Prabhakar N, Malhotra P, Agarwal R.

An unusual case of bullous hemorrhagic vasculitis in a COVID-19 patient

Negrini S, Guadagno A, Greco M, Parodi A, Burlando M.

Patients with specific skin disorders who are affected by COVID-19: what do experiences say about management strategies? : A systematic review

Najar Nobar N, Goodarzi A.

SARS-COV-2 As Possible Inducer of Viral Reactivations

Ciccarese G, Parodi A, Drago F.

Management of patients with Hidradenitis Suppurativa during the COVID-19 pandemic

Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S.

Dermatologic surgery in the COVID-19 era: observations and practical suggestions

Piccerillo A, Fossati B, Cappilli S, Sollena P.

SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection

Singh Y, Gupta G, Kazmi I, Al-Abbasi FA, Negi P, Chellappan D, Dua K.

''Treatment adherence in psoriatic patients during COVID-19 pandemic: Real-world data from a tertiary hospital in Greece''

Vakirlis AE, Bakirtzi K, Papadimitriou I, Vrani F, Sideris N, Lallas A, Ioannides D, Sotiriou E.

Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy

Del Giudice P, Boudoumi D, Le Guen B, Reverte M, Gutnecht J, Lacour JP, Kraemer JP, Motard A, Roa M.

Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection

Annunziata MC, Patrì A, Ruggiero A, Di Guida A, Menicanti C, Greco V, Fabbrocini G.

SARS-CoV-2 infection: the same virus can cause different cutaneous manifestations: reply from the authors

Galván Casas C, Català A, Carretero Hernández G, García-Doval I.

Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab

Facheris P, Valenti M, Pavia G, Gargiulo L, Narcisi A, Costanzo A, Borroni RG.

Covid-19: virtual occupational skin health clinics for healthcare workers

Chowdhury MM, Bevan N, Ryan K.

Third year Dermatology Resident Anxiety in the Era of COVID-19

Adusumilli NC, Eleryan M, Tanner S, Friedman AJ.

Fighting COVID-19: Early Teledermatology Lessons Learned

McGee JS, Reynolds RV, Olbricht SM.

Redeployment of Dermatologists During COVID-19: Implementation of a Large-Scale, Centralized Results Management Infrastructure

Ran NA, Samimi SS, Zhang J, Chaiyachati KH, Mallozzi CP, Hanson CW 3rd, Howell JT 3rd, Day SC, Mollanazar NK.

Comment on "Are erythema multiforme and urticaria related to a better outcome of COVID 19?". Eosinophils count in 7 patients with COVID-19 and urticarial rash

Jimenez-Cauhe J, Ortega-Quijano D, Suarez-Valle A, Dominguez-Santas M, Diaz-Guimaraens B, Fernandez-Nieto D.

Is herpes zoster being an indicator for COVID 19 infection?

Adam I.

Dermatological findings in SARS-CoV-2 positive patients: An observational study from North India

Dalal A, Jakhar D, Agarwal V, Beniwal R, Jakhar D, Agarwal V, Beniwal R.

Comment on "Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine": report of a COVID-19 patient with particular findings

Suarez-Valle A, Fernandez-Nieto D, Melian-Olivera A, Dominguez-Santas M, Diaz-Guimaraens B, Del Real CMG, Jimenez-Cauhe J.

Herpes Zoster (shingles) complicating the course of COVID19 infection

Elsaie ML, Nada HA.

Psoriasis and risk of the COVID-19 infection: Is there a role for Angiotensin Converting Enzyme (ACE)?

Shahidi-Dadras M, Tabary M, Robati RM, Araghi F, Dadkhahfar S.

Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID-19 pandemic: An experience from a tertiary hospital in Granada, Spain

Navarro-Triviño FJ, Ruiz-Villaverde R.

Treatment of Covid19 - Repurposing drugs commonly used in dermatology

Stojkovic-Filipovic J, Bosic M.

Modified mask for aesthetic procedures on face during COVID-19 era: chiseling our armamentarium

Noronha M, Jindal A, Mysore V.

Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19

Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I.

Lichenoid eruptions with interface dermatitis and necrotic subepidermal blister associated with COVID-19

Tehranchinia Z, Asadi-Kani Z, Rahimi H.

Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19

Enos T, Jeong HS, Vandergriff T, Jacobe HT, Chong BF.

Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre

Villani A, Megna M, Scalvenzi M, Fabbrocini G, Ruggiero A.

Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic

Kutlu Ö, Aktaş H, İmren IG, Metin A.

Observation and consideration on using of JAKi in clinical trials in times of COVID-19

Yang J, Maher AM, Li Y, An X, Tao J.

Utility and risk of dermatologic medications during the COVID-19 pandemic

Goldust M, Hartmann K, Abdelmaksoud A, Navarini AA.

COVID-19 HASTENS A STRUCTURAL SHIFT IN THE LCD MARKET

Dickson G.

Comment on "Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment"

Farabi B, Bhargava S, Goldust M, Atak MF.

The red half moon nail sign: a novel manifestation of Coronavirus infection

Neri I, Guglielmo A, Virdi A, Gaspari V, Starace M, Piraccini BM.

Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome

Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V.

Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom

Hadjieconomou S, Hughes J, Kamath S.

SARS-CoV-2, skin lesions and the need of a multidisciplinary approach

Cabrera-Hernández R, Solano-Solares E, Chica-Guzmán V, Fernández-Guarino M, Fernández-Nieto D, Ortega-Quijano D, de-Andrés-Martín A, Moreno C, Carretero-Barrio I, García-Abellás P, González-de-Olano D, de-la-Hoz-Caballer B.

"COVID-19-related acute genital ulcers"

Falkenhain-López D, Agud-Dios M, Ortiz-Romero PL, Sánchez-Velázquez A.

Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency

Ruggiero A, Megna M, Annunziata MC, Abategiovanni L, Scalvenzi M, Tajani A, Fabbrocini G, Villani A.

Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization

Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE, Eshaq M, Renati S, Nikle AB, Allen A, Hawkins SD, Huerta T, Lowe L, Andea AA.

Cutaneous autoimmune diseases during COVID 19 pandemic

Günther C, Aschoff R, Beissert S.

A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2?

Lipsker D.

Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic

Colonna C, Genovese G, Monzani NA, Picca M, Boggio F, Gianotti R, Marzano AV.

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic

Kearns DG, Uppal S, Chat VS, Wu JJ.

Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown

Iria N, Annalucia V, Ilaria C, Alba G, Tiziana L, Liliana G, Cosimo M, Annalisa P, Marcello L.

Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations

Drago F, Ciccarese G, Rebora A, Muzic SI, Parodi A.

Further aspects of doxycycline therapy in COVID-19

Szolnoky G.

Chilblains in children in the time of Covid-19: new evidence with serology assay

Colonna C, Spinelli F, Monzani NA, Ceriotti F, Gelmetti C.

Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description

Larrondo J, Cabrera R, Gosch M, Larrondo F, Aylwin M, Castro A.

Analysis of availability, types, and implementation of teledermatology services during COVID-19

Gorrepati PL, Smith GP.

COVID 19 and its impact on cosmetic dermatology

Galadari H, Gupta A, Kroumpouzos G, Kassir M, Rudnicka L, Lotti T, Berg RV, Goldust M.

Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology

Ho BWY, Wang D, Tan LYC, Bundele MM, Tan CH, Lim JH.

Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology

Rodríguez-Villa Lario A, Vega-Díez D, González-Cañete M, Gómez-Zubiaur A, Pérez-Mesonero R, Bandini M, Polo-Rodríguez I, Vélez-Velázquez D, Trasobares-Marugán L.

A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19

Caputo V, Schroeder J, Rongioletti F.

Urticaria in the times of COVID-19

Kaushik A, Parsad D, Kumaran MS.

Prevention of skin damage caused by the protective equipment used to mitigate COVID-19

Gefen A, Ousey K.

Shifting dermatology market strategies from cosmetics to moisturizers and sanitizers treatments in COVID-19 era

Schwartz RA, Pradhan S, Galadari H, Lotti T, Sharma A, Goldust M.

Change of the diagnostic distribution in applicants to dermatology after COVID-19 pandemic: What it whispers to us?

Turan Ç, Metin N, Utlu Z, Öner Ü, Kotan ÖS.

An unilateral purpuric rash in a patient with COVID-19 infection

Karaca Z, Yayli S, Çalışkan O.

Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort

Costa L, Tasso M, Scotti N, Mostacciuolo E, Girolimetto N, Foglia F, Del Puente A, Scarpa R, Caso F.

Response to: 'Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort' by Costa et al

Gupta L, Misra DP, Agarwal V, Balan S, Agarwal V.

Dermatological therapies with relevance to COVID-19

Shishak M, Sarkar R.

SARS-CoV, Mers-CoV and Covid-19:what differences from a dermatological viewpoint?

Rongioletti F.

Novel corona virus (COVID-19) disease and ophthalmic manifestations: Clinical evidences

Singh G, Sharma PK, Malviya R, Awasthi R.

Acute maculopapular eruption in Covid-19 patient: a case report

Rossi E, Lasagni C, Trakatelli M, Wertzberger Rowan S, Magnoni C.

The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases

Rubio-Muniz CA, Puerta-Peña M, Falkenhain-López D, Arroyo-Andrés J, Agud-Dios M, Rodriguez-Peralto JL, Ortiz-Romero PL, Rivera-Díaz R.

Urticaria (angioedema) and COVID- 19 infection

Najafzadeh M, Shahzad F, Ghaderi N, Ansari K, Jacob B, Wright A.

COVID-19 era: A chance to learn something new about monitoring psoriatic patients in biological therapy

Filippi F, Loi C, Evangelista V, Bardazzi F.

Rash as a presenting complaint in a child with COVID-19

Klimach A, Evans J, Stevens J, Creasey N.

Managing Psoriasis Consultations During the COVID-19 Pandemic: Recommendations from the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (AEDV)

Belinchón I, Puig L, Ferrándiz L, De La Cueva P, Carrascosa JM; en nombre del Grupo de Psoriasis de la AEDV.

Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19

Monte Serrano J, Cruañes Monferrer J, García-García M, García-Gil MF.

Mucosal involvement in a COVID-19-positive patient: a case report

Cebeci Kahraman F, ÇaŞkurlu H.

Recommendations on trichological treatments during COVID-19 pandemic

Rossi A, Magri F, Caro G, Federico A, Di Fraia M, Muscianese M, Fortuna MC, Carlesimo M.

Dermatology before, during and after COVID 19

van de Kerkhof PC.

Severity and risk of COVID-19 in cancer patients: An evidence based learning

Sharma A, Malviya R, Kumar V, Gupta R, Awasthi R.

Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model

Tejera-Vaquerizo A, Cañueto J, Toll A, Santos-Juanes J, Jaka A, Ferrandiz-Pulido C, Sanmartín O, Ribero S, Moreno-Ramírez D, Almazán F, Fuente MJ, Podlipnik S, Nagore E.

Skin changes attributed to protective measures against COVID-19: a compilation

Das A, Kumar S, Sil A, Jafferany M.

Artificial Intelligence in Diagnosis and Management of COVID-19 in Dermatology

Sadoughifar R, Goldust M, Abdshahzadeh H, Abrishamchi R, Rudnicka L, Jafferany M, Gupta M.

Omalizumab and COVID19 Treatment: Could It Help?

Abdelmaksoud A, Goldust M, Vestita M.

Azithromycin and COVID-19Prompt Early Use at First Signs of this Infection in Adults and Children An Approach Worthy of Consideration

Schwartz RA, Suskind RM.

Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: an alterative in Covid-19

Jindal A, Ramesh S, Noronha M, Pai K, Pai S.

Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?

de Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P, Selda-Enriquez G, Carretero I, Moreno C, Fern√°ndez-Guarino M.

Novel tip to prevent ear irritation with surgical face masks (FRSM) during the coronavirus (COVID-19) pandemic

Kainth GS.

A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever

Gargiulo L, Pavia G, Facheris P, Valenti M, Sacrini F, Narcisi A, Borroni R, Costanzo A, Mancini LL.

Comparative analysis of perceived stress in dermatologists and other physicians during home-quarantine and COVID-19 pandemic with exploration of possible risk factors- A web-based cross-sectional study from Eastern India

Podder I, Agarwal K, Datta S.

Insights into laser safety considerations during COVID 19 pandemic

Elsaie ML, Nada HA.

Evaluating the dermatology communities' public health response to COVID-19

Gorrepati PL, Smith GP.

Back to the Basics: Propolis and COVID-19

Bachevski D, Damevska K, Simeonovski V, Dimova M.

Skin amidst COVID-19 pandemic

Swarnkar B, Bhari N.

Virtual Conferences of dermatology during the COVID-19 Pandemic

Goldust M, Shivakumar S, Kroumpouzos G, Murrell DF, Rudnicka L, Jafferany M, Navarini AA.

Safety Measures in Dermatology Help Minimize Spread of COVID-19

Goren A, Rathod D, Kroumpouzos G, Jafferany M, Goldust M.

The risk of hand eczema in healthcare workers during the COVID-19 pandemic: Do we need specific attention or prevention strategies?

Erdem Y, Altunay IK, Aksu Çerman A, Inal S, Ugurer E, Sivaz O, Kaya HE, Gulsunay IE, Sekerlisoy G, Vural O, Özkaya E.

Teledermatology during COVID 19 pandemic: ethical and legal considerations about the principles of treatment prescription and privacy

Elmas ÖF, Demirbaş A, Atasoy M, Türsen Ü, Lotti T.

Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy

Vezzoli P, Di Mercurio M, Carugno A, Gambini DM, Robustelli Test E, Imberti G, Castagna AF, Sena P.

Geriatric Skin Care in the Era of COVID-19

Golpanian RS, Yosipovitch G.

Analysis of dermatology-related search engine trends during the COVID-19 pandemic: implications for patient demand for outpatient services and telehealth

Guzman AK, Barbieri JS.

Considerations for Underrepresented in Medicine Dermatology Residency Applicants Amidst the COVID-19 Pandemic

Jones VA, Clark KA, Patel PM, Cordova A, Tsoukas MM.

CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC ("COVID TOES"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES

Kanitakis J, Lesort C, Danset M, Jullien D.

Challenges faced by patients with morphea in the era of SARS-CoV-2

Shahidi Dadras M, Namazi N, Nikvar M, Abdollahimajd F.

The Aftermath of COVID-19 in Dermatology Practice: What's next?

Ng JN, Cembrano KAG, Wanitphakdeedecha R, Manuskiatti W.

Melanoma defies 'lockdown': ongoing detection during Covid-19 in central London

Schauer AA, Kulakov EL, Martyn-Simmons CL, Bunker CB, Edmonds E.

Psoriasis-COVID 19 Infection: Treatment Options

Tampouratzi E, Kanni T, Katsantonis J, Douvali T.

Which are the "emergent" dermatologic practices during COVID-19 pandemic? Report from the lockdown in Milan, Italy

Giacalone S, Bortoluzzi P, Nazzaro G.

Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: a single-center real-life experience

Rossi M, Rovati C, Arisi M, Soglia S, Calzavara-Pinton P.

Global Coronavirus Pandemic (SARS CoV-2): Past, Present, And Future Of Pediatric Dermatology

Simonetti O, Diotallevi F, Campanati A, Brisigotti V, Radi G, Molinelli E, Bobyr I, Martina E, Paolinelli M, Sapigni C, Offidani A.

Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl

Yozgat CY, Uzuner S, Duramaz BB, Yozgat Y, Erenberk U, Iscan A, Turel O.

Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like"

Mahé A, Birckel E, Merklen C, Lefèbvre P, Hannedouche C, Jost M, Droy-Dupré L.

"Thinking outside the box in COVID-19 era"-Application of Modified Aerosol Box in Dermatology

Babu B, Shivakumar S, Dr Asokan K.

Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis

Demirbaş A, Elmas ÖF, Türsen Ü, Atasoy M, Lotti T.

Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19

Wollina U.

Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic

Earnshaw CH, Hunter HJA, McMullen E, Griffiths CEM, Warren RB.

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic

Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.

Dermatopathology Education During the COVID-19 Pandemic: Virtual Simulation of the Multi-Headed Microscope

Kim RH, Brinster NK, Meehan SA.

Effectively Engaging Geriatric Patients via Teledermatology

Simpson CL, Kovarik CL.

Challenges and countermeasures in the prevention of nosocomial infections of SARS-CoV-2 before resumption of work: implications for the dermatology department

Zhang Y, Wen J, Chen C, Zeng L, Yang L, Huang C, Feng A, Miao X, Alamgir M, Rao B, Li Y, Tao J.

Modifications to Dermatology Residency Education During the COVID-19 Pandemic

Mufti A, Maliyar K, Sachdeva M, Doiron P.

Chilblain-like lesions during the COVID-19 pandemic: should we really worry?

Piccolo V, Neri I, Manunza F, Mazzatenta C, Bassi A.

Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care

Kerber AA, Soma DB, Youssef MJ.

Protection comes at a cost: Doctor's life inside Personal Protection Equipment

Bhargava S, Gupta M, Kroumpouzos G.

Virtual dermatopathology: A potential educational tool during COVID-19 pandemic

Khullar G, Chandra M.

Eosinophilic granulomatosis with polyangiitis mimicking COVID-19: a case report

Hashizume H, Sano Y, Furukawa S, Imokawa S.

Recommendations for Treatment of Nail Psoriasis During the COVID-19 Pandemic

Ricardo JW, Lipner SR.

Laser Safety Measures for The Treatment of Genital Warts in Hiv+ Patients During The Covid-19 Pandemic

Cameli N, Mariano M, Latini A, Morrone A, Cristaudo A.

Pression-induced facial ulcers by prone position for COVID-19 mechanical ventilation

Ramondetta A, Ribero S, Costi S, Dapavo P.

Safeguarding Dermatologist Attendings and Residents Amid the COVID-19 Pandemic: Focus on Special Populations

Stewart CR, Lipner SR.

Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?

Rosell-Díaz AM, Mateos-Mayo A, Nieto-Benito LM, Balaguer-Franch I, Hernández de E, la Torre-Ruiz, Laínez-Nuez A, Suárez-Fernández R, Bergón-Sendín M.

Iatrogenic dermatitis in times of COVID-19: A pandemic within a pandemic

Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M, Gupta S.

Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients

Reymundo A, Fernáldez-Bernáldez A, Reolid A, Butrón B, Fernández-Rico P, Muñoz-Hernández P, De Argila D, Llamas-Velasco M.

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?

Marasca C, Ruggiero A, Napolitano M, Fabbrocini G, Megna M.

Dermatological insights from Google Trends: what does the public think is important during COVID-19 lockdown?

Searle T, Al-Niaimi F, Ali FR.

Retiform purpura as a dermatological sign of covid-19 coagulopathy

Bosch-Amate X, Giavedoni P, Podlipnik S, Andreu-Febrer C, Sanz-Beltran J, Garcia-Herrera A, Alós L, Mascaró JM Jr.

COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy

Gaspari V, Neri I, Misciali C, Patrizi A.

Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice

Sacchelli L, Viviani F, Orioni G, Rucci P, Rosa S, Lanzoni A, Patrizi A, Gaspari V.

Retroauricular dermatitis with vehement use of ear loop face masks during COVID19 pandemic

Bothra A, Das S, Singh M, Pawar M, Maheswari A.

Teledermatology for acne patients: how to reduce face-to-face visits during COVID-19 pandemic

Villani A, Annunziata MC, Abategiovanni L, Fabbrocini G.

Pitfalls of possible reporting of same patients with COVID-19 in dermatology journals

Kluger N.

No antibody response in acral cutaneous manifestations associated with COVID-19 ?

Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, Le Corre Y, Vandamme YM.

Hand Eczema Pandemic Caused by SARS-CoV-2 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital Personnel

Greveling K, Kunkeler ACM.

Acro-ischemia and COVID-19 infection: clinical and histopathological features

Calv√£o J, Relvas M, Pinho A, Brinca A, Cardoso JC.

Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms

Criado PR, Abdalla BMZ, de Assis IC, van Blarcum de Graaff Mello C, Caputo GC, Vieira IC.

Bilateral viral pneumonia by COVID-19 as a chance finding in staging with (18)F-FGD-PET/CT of patient with right calf melanoma

Gómez-Caminero-López F, García-Talavera-San-Miguel P, Lucas Velázquez B, García Arroyo J, Díaz González LG, Gómez Grande A.

Advances in skin science enable the development of a COVID-19 Vaccine

Falo LD Jr.

Increasing melanoma awareness amongst health and social care professionals in secondary care in an era of reduced skin cancer referrals

Quinlan C, Gill R, Murphy M.

COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?

Wei C, Friedman AJ.

Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries

Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Takeshita J, French LE, Thiers BH, Hruza GJ, Fox LP; American Academy of Dermatology Ad Hoc Task Force on Covid-19.

Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue

Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA.

Bullous skin disease patients in a high-epidemic COVID-19 area, Bergamo, Italy

Carugno A, Sena P, Raponi F, Robustelli Test E, Vezzoli P.

Psoriatic Arthritis and COVID-19 Pandemic: Consequences in Medical Treatment?

Wollina U, Fioranelli M, Goldust M, Lotti T.

How Can I Take Care Of You? The Dermatologist Meets Patients' Needs During The Covid19 Pandemic

Radi G, Simonetti O, Diotallevi F, Campanati A, Brisigotti V, Molinelli E, Offidani A.

Topical rh-aFGF: An effective therapeutic agent for facemask wearing-induced pressure sores

Luo P, Liu D, Li J.

Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-west Poland

Białynicki-Birula R, Siemasz I, Otlewska A, Matusiak Ł, Szepietowski JC.

Covid-19 infection in psoriasis patients treated with cyclosporin

Di Lernia V, Goldust M, Feliciani C.

Psoriasis, biologic therapy, and the pandemic of the 21st century

Nogueira M, Vender R, Torres T.

Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment

Magnano M, Balestri R, Bardazzi F, Mazzatenta C, Girardelli CR, Rech G.

Potential role of Anti-IL-17 in COVID-19 treatment

Ayhan E, Öztürk M, An İ, Abdelmaksoud A, Araç E.

Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic

Melis D, Mugheddu C, Sanna S, Atzori L, Rongioletti F.

Contributions of dermatologists to COVID-19 research: a brief systematic review

Wang Y, Fang R, Zhang H, Tang K, Sun Q.

The Clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease

Dursun R, Temiz SA.

COVID-19 and ectodermal dysplasias. Recommendations are necessary

Callea M, Willoughby CE, Perry D, Holzer U, Fedele G, C√°rdenas Tadich A, Cammarata-Scalisi F.

Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab

Valenti M, Facheris P, Pavia G, Gargiulo L, Borroni RG, Costanzo A, Narcisi A.

Recommendations for Diagnosis and Treatment of Onychomycosis During the COVID-19 Pandemic

Lipner SR, Ricardo JW.

Mental Health Status of Dermatologists during the COVID-19 Pandemic; A Technology-based Therapy

Goldust M, Agarwal K, Kroumpouzos G, Jafferany M, Lotti T, Podder I.

A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection

El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R.

Impact of Covid 19 pandemic on obsessive compulsive and related disorder patients- Psychodermatological perspectives

Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed Razmi T.

Treatment of COVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?

Seirafianpour F, Mozafarpoor S, Fattahi N, Sadeghzadeh-Bazargan A, Hanifiha M, Goodarzi A.

Palliative psychodermatology care during COVID-19 pandemic

Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed RT.

Increased Flare of Acne Caused by Long-Time Mask Wearing During COVID-19 Pandemic among General Population

Han C, Shi J, Chen Y, Zhang Z.

Cutaneous manifestations in COVID-19: a skin rash in a child

Olisova OY, Anpilogova EM, Shnakhova LM.

"COVID-Mask": an atypical livedoid manifestation of COVID-19 observed in a northern Italy hospital

Conforti C, Zalaudek I, Giuffrida R, Zorat F, Grillo A, Colapietro N, Francica M, di Meo N.

Virtual melanoma checks during a pandemic

Janda M, Swetter SM, Horsham C, Soyer HP.

Absence of Skin of Colour Images in Publications of COVID-19 Skin Manifestations

Lester JC, Jia JL, Zhang L, Okoye GA, Linos E.

Novel Coronavirus Disease (COVID-19) and Biologic Therapy for Psoriasis: Successful Recovery in Two Patients After Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt

Villani A, Fabbrocini G, Costa C, Scalvenzi M.

Virtual dermatology: a COVID-19 update

Bressler MY, Siegel DM, Markowitz O.

Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post COVID-19 era: Time to reconsider its role for most patients

Veness M.

Aesthetıc dermatology procedures ın coronavırus-days

Türsen Ü, Türsen B, Lotti T.

Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection

Hughes M, Rogers S, Lepri G, Bruni C, Matucci-Cerinic M.

Use of systemic therapies for psoriasis in the COVID-19 era

Kearns DG, Uppal S, Chat VS, Wu JJ.

Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy

Brunasso AMG, Massone C.

Restructuring an Academic Dermatology Practice During the COVID-19 Pandemic

Sheriff T, Murrell OG, Murrell DF.

Cutaneous manifestations of COVID-19: A review of the published literature

Elmas ÖF, Demirbaş A, Özyurt K, Atasoy M, Türsen Ü.

Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID-19 pandemic

Ricardo JW, Lipner SR.

Store-and-forward Teledermatology in the era of COVID-19: A Pilot Study

Cartron AM, Rismiller K, Trinidad JCL.

Immunosuppressive and immunomodulator therapy for rare or uncommon skin disorders in pandemic days

Karadag AS, Aslan Kayıran M, Lotti T, Wollina U.

Patients with bullous disorders during COVID-19 period: management and adherence to treatment

De Fata Salvatores G, Villani A, Fabbrocini G, Di Guida A.

[Acro-ischemic skin lesions during COVID-19 epidemic]

Monte Serrano J, Cruañes Monferrer J, García-Gil MF.

Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E.

Late onset of acral necrosis after SARS-CoV-2 infection resolution

Balestri R, Termine S, Rech G, Girardelli CR.

The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities

Rossi E, Trakatelli M, Giacomelli L, Ferrari B, Francomano M, Pellacani G, Magnoni C.

A case of cefditoren-induced Acute Generalized Exanthematous Pustulosis during COVID-19 pandemics. Severe Cutaneous Adverse Reactions (SCARs) are an issue

Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-Estrada R.

COVID-19 in a melanoma patient under treatment with checkpoint-inhibition

Schmidle P, Biedermann T, Posch C.

Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN)

Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M.

Chilblains-like lesions and COVID-19

Joob B, Wiwanitkit V.

Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19)

Dominguez-Santas M, Diaz-Guimaraens B, Garcia Abellas P, Moreno-Garcia Del Real C, Burgos-Blascoª P, Suarez-Valle A.

Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review

Docampo-Simón A, Sánchez-Pujol MJ, Juan-Carpena G, Palazón-Cabanes JC, Vergara-De Caso E, Berbegal L, Poveda-Montoyo I, Pastor-Tomás N, Mataix-Díaz J, Terencio-Alemany C, Martínez-Torres A, Miralles-Botella J, Blanes-Martínez M, González-Villanueva I, Betlloch-Mas I.

COVID-19 Presenting with Atypical Sweet's Syndrome

Taşkın B, Vural S, Altuğ E, Demirkesen C, Kocatürk E, Çelebi İ, Ferhanoğlu B, Alper S.

Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic - comparing a single surgical site with a COVID-19 intensive care unit

Guertler A, Moellhoff N, Schenck TL, Hagen CS, Kendziora B, Giunta RE, French LE, Reinholz M.

How well prepared are dermatologists redeployed to COVID-19 wards?

Plachouri KM, Georgiou S.

Recommendations for Medical Student Preparedness and Equity for Dermatology Residency Applications During the COVID-19 Pandemic

Stewart CR, Chernoff KA, Wildman HF, Lipner SR.

Face Mask-induced Itch: A Self-questionnaire Study of 2,315 Responders During the COVID-19 Pandemic

Szepietowski JC, Matusiak Ł, Szepietowska M, Krajewski P, Białynicki-Birula R.

Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes

Nassim D, Jfri A, Litvinov IV, Netchiporouk E.

Apremilast as a potential treatment option for COVID-19: no symptoms of infection in a psoriatic patient

Yu Olisova O, Anpilogova EM, Svistunova DA.

Can COVID 19 virus be transmitted through sex?

Hafi B, Uvais NA, Jafferany M, Afra TP, Muhammed Razmi T.

Can Covid-19 be a sexually transmitted disease? Posterity will judge

Gaspari V, Lanzoni A, Patrizi A, Orioni G, Viviani F, Bardazzi F.

Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists

Kaur I, Sharma A, Jakhar D, Das A, Aradhya SS, Sharma R, Jindal V, Mhatre M.

Is climate change the next pandemic for dermatology? Lessons from COVID-19

Patruno C, Nisticò SP, Fabbrocini G, Napolitano M.

Herpes zoster might be an indicator for Latent COVID 19 infection

Elsaie ML, Youssef EA, Nada HA.

Moderate to severe hidradenitis suppurativa under systemic therapy during the COVID-19 outbreak

Giulia R, Alice R, Teresa FM, Paolo D, Simone R.

Are erythema multiforme and urticaria related to a better outcome of COVID 19?

Dastoli S, Bennardo L, Patruno C, Nisticò SP.

The explosion in scabies cases during COVID-19 pandemic

Kutlu Ö, Aktaş H.

Dermatological findings in COVID-19 patients: Mexican experience

Macedo-Pérez M, Barragán-Estudillo ZF, Castillo-Montufar E, Choi SJ, Fernández-Rueda P, Donis-Hernández J, Virgen-Cuevas MM, López-Enriquez CC, Martínez-Hernández L, Carballo-Zarate AA, Leal-Osuna SE.

COVID-19, quarantine, and atopic dermatitis

Patruno C, Nisticò SP, Fabbrocini G, Napolitano M.

Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions

Piccolo V, Bassi A.

Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions"

D FN, J JC, A SV, Om MA, D SC, A AR, D OQ.

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign"

Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Pascual PF, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A.

Skin findings in the COVID-19 pandemic in the Region of Murcia

Pérez-Suárez B, Martínez-Menchón T, Cutillas-Marco E.

Erythema multiforme-like lesions in children and COVID-19

Torrelo A, Andina D, Santonja C, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I.

Atypical erythema nodosum in a patient with COVID-19 pneumonia

Ordieres-Ortega L, Toledo-Samaniego N, Parra-Virto A, Fernández-Carracedo E, Lavilla-Olleros C, Demelo-Rodríguez P.

Diagnostic and prognostic values of cutaneous manifestations in COVID-19

Suchonwanit P, Leerunyakul K, Kositkuljorn C.

"Masked" empathy- a post-pandemic reality: Psychodermatological perspective

Hafi NAB, Jafferany M, Afra TP, Muhammed Razmi T, Uvais NA.

Management of Telogen Effluvium During The Covid-19 Emergency: Psychological Implications

Rivetti N, Barruscotti S.

Current Applications of Artificial Intelligence for COVID-19

Jakhar D, Kaur I.

Reply to "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients": To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out

Llamas-Velasco M, Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Daudén E.

Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19 treatment

Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J.

Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out"

Marzano AV, Genovese G.

Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy

De Giorgi V, Recalcati S, Jia Z, Chong W, Ding R, Deng Y, Scarfi F, Venturi F, Trane L, Gori A, Silvestri F, Gao XH, Lotti T.

Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report

Mayor-Ibarguren A, Feito-Rodriguez M, Quintana Castanedo L, Ruiz-Bravo E, Montero Vega D, Herranz-Pinto P.

Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19

Guarneri C, Venanzi Rullo E, Gallizzi R, Ceccarelli M, Cannavò SP, Nunnari G.

Where do we stand as dermatologists in combat with COVID-19

Goldust M, Shivakumar S, Kroumpouzos G, Murrell DF, Mueller SM, Navarini AA.

COVID-19 and its implications for Dermatology and Venereology

Ring J.

Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China

Long H, Zhao H, Chen A, Yao Z, Cheng B, Lu Q.

Will Teledermatology be the silver lining during and after COVID-19?

Sharma A, Jindal V, Singla P, Goldust M, Mhatre M.

Evaluation Of Dermatology Consultations In The Era Of COVID19

Temiz SA, Dursun R, Daye M, Ataseven A.

Management of Pemphigus in COVID-19 Pandemic Era; a Review Article

Abdollahimajd F, Shahidi-Dadras M, M Robati R, Dadkhahfar S.

SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children

Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, Montin D.

Dermatologic manifestations of hydroxychloroquine therapy: a closer look at the nails

Lipner SR, Scher RK.

Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection

Llamas-Velasco M, Chicharro P, Rodríguez-Jiménez P, Martos-Cabrera L, De Argila D, Fernández-Figueras M, Fraga J.

Viral Exanthem with "Pin and Needles Sensation" on Extremities of COVID-19 Patient

Putra BE, Adiarto S, Dewayanti SR, Juzar DA.

Silent COVID-19: what your skin can reveal

Guarneri C, Rullo EV, Pavone P, Berretta M, Ceccarelli M, Natale A, Nunnari G.

Dermatology Department: What we could do amidst the pandemic of COVID-19?

Abedini R, Ghandi N, Lajevardi V, Ghiasi M, Nasimi M.

Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic

Ferrara G, Morgado-Carrasco D.

Immunosuppressive agents for dermatological indications in the ongoing COVID 19 pandemic: rationalizing use and clinical applicability

Khurana A, Saxena S.

A case of goggle-mask-related impetigo at the time of the COVID-19 pandemic

Yu Q, Li W, Yang L.

Makeshift face shield for healthcare professionals during the COVID-19 pandemic

Gupta S, Jangra RS, Gupta S, Gujrathi AV, Sharma A.

The fear of COVID-19 infection is the main cause of the new diagnoses of hand eczema: report from the frontline in Milan

Giacalone S, Bortoluzzi P, Nazzaro G.

Covid-19 and Exacerbation of Psoriasis

Ozaras R, Berk A, Ucar DH, Duman H, Kaya F, Mutlu H.

Hidden threat lurking behind the alcohol sanitizers in CoVID-19 outbreak

Emami A, Javanmardi F, Keshavarzi A, Pirbonyeh N.

Managing patients with choroidal melanoma in the COVID-19 era: a personal perspective

Damato B.

Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic

García-Gil MF, García García M, Monte Serrano J, Prieto-Torres L, Ara-Martín M.

Is Biologic Treatment of Hidradenitis Suppurativa During the COVID-19 Pandemic Different from Psoriasis Biologic Treatment?

Rosi E, Pimpinelli N, Prignano F.

Balancing aesthetic and conventional dermatology practice in the COVID-19 era

Arora G, Jafferany M, Arora S.

Skin-to-Skin Care and COVID-19

Boscia C.

Immunosuppressive treatment for systemic sclerosis - therapeutic challenges during the COVID-19 pandemic

Blicharz L, Czuwara J, Samochocki Z, Goldust M, Olszewska M, Rudnicka L.

COVID-19 and Dermatology: A Comprehensive Guide for Dermatologists

Fahmy DH, El-Amawy HS, El-Samongy MA, Foud AA, Soliman SH, El-Kady A, Farnetani F, Conti A, Zoeir A, Eissa A, Eissa R, Puliatti S, Sighinolfi MC, Rocco B, Pellacani G.

Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?

Goldust M, Abdelmaksoud A, Shuang Z, Xiang C, Navarini AA.

Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit

Quaglino P, Fava P, Brizio M, Marra E, Rubatto M, Agostini A, Tonella L, Ribero S, Fierro MT.

A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema

Herrero-Moyano M, Capusan TM, Andreu-Barasoain M, Alcántara-González J, Ruano-Del Salado M, Sánchez-Largo Uceda ME, Calzado-Villarreal L, Pérez-González Y.

Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of literature

Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M, Radi G, Rizzetto G, Sapigni C, Tagliati C, Offidani A.

Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?

Sakaida T, Isao T, Matsubara A, Nakamura M, Morita A.

Retrospective Analysis of Smell and Taste Disturbances Associated with Dermatological Medications Reported to the United States Food and Drug Administration and Relevance to COVID-19 Infections

Wang Y, Lipner SR.

Opportunistic virus infections in psoriasis patients: the safer alternative of apremilast

Armesto S, González Vela C, González López MA.

The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era

Mastrolonardo M, Romita P, Bonifazi E, Giuffrida R, Lotti T, Foti C, Bonamonte D.

THERAPY FOR PROBABLE COVID-19 ASSOCIATED ERYTHEMA PERNIO-LIKE LESIONS IN PEDIATRIC AGE. CASE REPORT

Ruggiero G, Arcangeli F, Lotti T.

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Yekedüz E, Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, Utkan G, Ürün Y.

Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?

Skayem C, Cassius C, Ben Kahla M, Fiani C, Frumholtz L, Mrad M, Petit A, Zuelgaray E, Bagot M, Bouaziz JD, Duong TA.

The Immediate Impact of COVID-19 on US Dermatology Practices

Litchman GH, Rigel DS.

Cutaneous Manifestations of COVID-19: A Preliminary Review

Jia JL, Kamceva M, Rao SA, Linos E.

Spanish Dermatology in the COVID-19 Era

Romaní J.

Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled study.

Dong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J.

A late onset widespread skin rash in a previous Covid-19 infected patient: viral or multidrug effect?

Skroza N, Bernardini N, Balduzzi V, Mambrin A, Marchesiello A, Michelini S, Tolino E, Proietti I, Di Cristofano C, Petrozza V, Potenza C.

Chilblain acral lesions in the COVID -19 era. Are they marker of infection in asymptomatic patients?

Ramondetta A, Panzone M, Dapavo P, Ortoncelli M, Giura MT, Licciardello M, Rozzo G, Siliquini N, Fierro MT, Ribero S.

Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.

Saenz Aguirre A, De la Torre Gomar FJ, Rosés-Gibert P, Gimeno Castillo J, Martinez de Lagrán Alvarez de Arcaya Z, Gonzalez-Perez R.

Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology?

Valenti M, Gargiulo L, Pavia G, Facheris P, Borroni R, Narcisi A, Costanzo A.

[Perniosis-like skin lesions during the COVID-19 epidemic]

Monte Serrano J, Cruañes Monferrer J, Matovelle Ochoa C, García-Gil MF.

[After Covid-19: Towards a new dermatology?]

Petit A, Martin L, Penso-Assathiany D, Consoli S, Assouly P, Velter C, Hefez L, Debarre JM, Haddad L; Groupe de réflexion éthique en dermatologie (GéD).

Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic

Rembielak A, Sykes AJ, Fife K, Challapalli A, Nobes JP.

Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.

Aktaş H, Hamidi AA.

The COVID-19 chemoprophylactic conundrum - Are we limiting available resources?

Sharma A, Mhatre M, Goldust M, Jindal V, Singla P.

Algorithm for the classification of Covid-19 rashes.

Ortega-Quijano D, Jimenez-Cauhe J, Selda-Enriquez G, Fernandez-Guarino M, Fernandez-Nieto D.

Reply to: Skin damage among healthcare workers managing coronavirus disease-2019.

Maliyar K, Sachdeva M, Mufti A, Yeung J.

The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic

Wan MT, Shin DB, Winthrop KL, Gelfand JM.

COVID-19 & PPE: Treatment and Prevention of Skin Conditions Related to the Occupational Use of Personal Protective Equipment

Desai SR, Kovarik C, Brod B, James W, Fitzgerald ME, Preston A, Hruza GJ.

A targeted response to the COVID-19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals.

Corden E, Rogers A, Woo WA, Simmonds R, Mitchell C.

[What can we learn from the COVID-19 pandemic in general and about ourselves as dermatologists?]

Kluger N.

COVID-19 and its impact on medical student education in dermatology.

Dear Dermatoethicist: Web-Based Dermatology Residency Interviews in the Time of COVID-19.

Recommendations for personal protective equipment and smoke evacuation for dermatologic surgeries amid the COVID-19 crisis.

Do MH, Minkis K, Petukhova TA, Lipner SR.

COVID-19 and dermatologic surgery: hazards of surgical plume.

Al-Niaimi F, Ali FR.

Appearance of Skin Rash in Pediatric Patients with COVID-19: Three Case Presentations.

Duramaz BB, Yozgat CY, Yozgat Y, Turel O.

Hirsutism, Amphetamines, COVID-19 Viral Shedding, Hand-Foot-and-Mouth Disease.

[No authors listed]

Follow-up of skin lesions during the evolution of COVID-19: a case report.

de Medeiros VLS, Silva LFT.

Skin Involvement in SARS-CoV-2 Infection: Case Series.

Diotallevi F, Campanati A, Bianchelli T, Bobyr I, Luchetti MM, Marconi B, Martina E, Radi G, Offidani A.

Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic.

Cinelli E, Megna M, Di Guida A, Greco V, Annunziata MC, Fabbrocini G.

Follow-up of skin lesions during the evolution of COVID-19: a case report.

Skin manifestations of COVID-19.

Young S, Fernandez AP.

Cutaneous manifestations in COVID-19: Family cluster of Urticarial Rash.

Cepeda-Valdes R, Carrion-Alvarez D, Trejo-Castro A, Hernandez-Torre M, Salas-Alanis J.

A survey of psoriasis patients on biologics during COVID-19: a single centre experience.

Burlando M, Carmisciano L, Cozzani E, Parodi A.

Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic.

Shah M, Sachdeva M, Alavi A, Shi VY, Hsiao JL.

Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).

Stroppa EM, Toscani I, Citterio C, Anselmi E, Zaffignani E, Codeluppi M, Cavanna L.

[Chilblains in lockdown: An old acquaintance in the context of COVID-19].

COVID-19 and the Skin.

Catal√° Gonzalo A, Galv√°n Casas C.

Is the Coronavirus (COVID-19) Pandemic an Indication to Temporarily Modify Dermatological Management Plans?

A case of COVID-19 pneumonia presenting with acute urticaria.

Naziroğlu T, Sözen S, Özkan P, Şeker S, Aksu K.

Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine.

Litaiem N, Hajlaoui K, Karray M, Slouma M, Zeglaoui F.

The effect of the "stay-at-home" policy on requests for dermatology outpatient clinic visits after the COVID-19 outbreak.

Kutlu Ö, Güneş R, Coerdt K, Metin A, Khachemoune A.

N95 respirator associated pressure ulcer amongst COVID-19 health care workers.

Lam UN, Md Mydin Siddik NSF, Mohd Yussof SJ, Ibrahim S.

Clustered Cases of Acral Perniosis: Clinical Features, Histopathology and Relationship to COVID-19.

Cordoro KM, Reynolds SD, Wattier R, McCalmont TH.

Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 cases.

Singh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A.

Dermatological procedures amidst Covid-19: when and how to resume.

Jindal A, Noronha M, Mysore V.

Dermatologic Treatments In The Era Of The Covid 19 Pandemics - Data And Hypothesis.

Sadoughifar R, Goldust M, Kroumpouzos G, Szepietowski JC, Lotti T, Sandhu S.

Periorbital Erythema as a Presenting Sign of Covid-19.

Kalner S, Vergilis IJ.

The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology.

Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?

Ghazal S, Litvinov IV, Aljahani N, Jfri A, Netchiporouk E.

Cutaneous Signs in COVID-19 Patients: A Review.

Wollina U, Karadağ AS, Rowland-Payne C, Chiriac A, Lotti T.

Recommendations for Treatment of Nail Lichen Planus During the COVID-19 Pandemic.

Ricardo JW, Lipner SR.

Mask-induced contact dermatitis in handling COVID-19 outbreak.

Xie Z, Yang YX, Zhang H.

Resuming work gradually in the context of COVID-19: experience from a tertiary dermatology department in China.

Tang K, Zhang H, Jin H.

Impact of COVID-19 outbreak on dermatology services: Dermatology in isolation.

Damevska K, Neloska L, Simeonovski V, Petrov A, Dimitrovska I, Teovska-Mitrevska N, Najdova A, Pollozhani N.

Preventing adverse cutaneous reactions from amplified hygiene practices during the COVID-19 pandemic: how dermatologists can help through anticipatory guidance.

MacGibeny MA, Wassef C.

Histologic features of long lasting chilblain-like lesions in a pediatric COVID-19 patient.

Locatelli AG, Robustelli Test E, Vezzoli P, Carugno A, Moggio E, Consonni L, Gianatti A, Sena P.

Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.

Robustelli Test E, Vezzoli P, Carugno A, Raponi F, Gianatti A, Rongioletti F, Sena P.

Reply to "Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection": Urticaria-like lesions in COVID-19 patients are not really urticaria. A case with clinicopathologic correlation.

Rodríguez-Jiménez P, Chicharro P, De Argila D, Muñoz-Hernández P, Llamas-Velasco M.

Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.

Janah H, Zinebi A, Elbenaye J.

Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemic.

Campbell V, Middleton D, Donnelly J, Hunter H.

Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient.

Sernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T.

Dermatologic Surgery Training during the COVID-19 era.

García-Lozano JA, Cuellar-Barboza A, Garza-Rodríguez V, Vázquez-Martínez O, Ocampo-Candiani J.

Urticarial eruption in Coronavirus Disease 2019 (COVID-19) infection: a case report in Tangerang, Indonesia.

Gunawan C, Angela, Widysanto A.

A Dermatologist's Perspective of the COVID-19 Outbreak.

Murrell DF, Arora G, Rudnicka L, Kassir M, Lotti T, Goldust M.

Coronavirus Disease-2019 with Dermatologic Manifestations and Implications: An Unfolding Conundrum.

Almutairi N, Schwartz RA.

COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management.

Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F.

Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.

Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia Del Real C, Fernandez-Nieto D.

Balancing public health and private wealth: lessons on climate inaction from the COVID-19 pandemic - a report from the International Society of Dermatology Climate Change Committee.

Coates SJ, Andersen LK, Boos MD.

Hand eczema - a growing dermatological concern during the COVID-19 pandemic and possible treatments.

Blicharz L, Czuwara J, Samochocki Z, Goldust M, Chrostowska S, Olszewska M, Rudnicka L.

Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital.

Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, Burgos-Blasco P, de Perosanz-Lobo D, Suarez-Valle A, Cortes-Cuevas JL, Carretero I, Garcia Del Real CM, Fernandez-Guarino M.

The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.

Shah M, Sachdeva M, Dodiuk-Gad RP.

Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): a brief review.

Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q.

Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.

El-Azhary R.

Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC; COVID-19 Global Rheumatology Alliance..

Dealing with Skin Reactions to Gloves During the COVID-19 Pandemic.

Tabary M, Araghi F, Nasiri S, Dadkhahfar S.

Improvement of SARS-CoV2 symptoms following Guselkumab injection in a psoriatic patient.

Benhadou F, Del Marmol V.

Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugs.

Conti A, Lasagni C, Bigi L, Pellacani G.

SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routes.

Delfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G.

Comprehensive overview of COVID-19 based on current evidence.

Kang Y, Xu S.

Drug-induced vasculitis in a patient with COVID-19.

Ramirez AV, Efe D, Fischer M.

Symmetric cutaneous vasculitis in COVID-19 pneumonia.

Castelnovo L, Capelli F, Tamburello A, Maria Faggioli P, Mazzone A.

Acro-ischemia in hospitalized COVID-19 patients.

Suarez-Valle A, Fernandez-Nieto D, Diaz-Guimaraens B, Dominguez-Santas M, Carretero I, Perez-Garcia B.

What is the role of a dermatologist in the battle against COVID-19? The experience from a hospital on the frontline in Milan.

Nazzaro G, Marzano AV, Berti E.

Use of Face Masks in Dermatology Department During the COVID-19 Outbreak.

Goldust M, Kroumpouzos G, Murrell DF, Jafferany M, Lotti T, Wollina U, Shivakumar S.

Update on COVID-19 Effects in Dermatology Specialty.

Goldust M, Kroumpouzos G, Murrell DF, Rudnicka L, Das A, Lotti T, Navarini AA.

Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak.

Garcia-Lara G, Linares-González L, Ródenas-Herranz T, Ruiz-Villaverde R.

To resume outpatient dermatologic surgery safely during stabilized period of coronavirus disease-2019: experiences from Wuhan, China.

Yang L, Song Z, Qian Y, Tao J.

Rescheduling of clinical activities and teleconsulting for public dermatology. Two prompt answers to COVID-19 emergency.

Morrone A, Cristaudo A, Ardigò M, Frascione P, Pacifico A, Giuliani M.

Chilblains-like lesions in children following suspected Covid-19 infection.

Colonna C, Monzani NA, Rocchi A, Gianotti R, Boggio F, Gelmetti C.

Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic.

López-Robles J, de la Hera I, Pardo J, Martínez J, Cutillas-Marco E.

Observations about sexual and other routes of SARS-CoV-2 transmission and its prevention.

Tatu AL, Nadasdy T, Nwabudike LC.

Cutaneous Manifestations of a 21st Century Worldwide Fungal Epidemic Possibly Complicating the COVID-19 Pandemic to Jointly Menace Mankind.

Schwartz RA, Kapila R.

The Response of Women's Dermatologic Society and the International Journal of Women's Dermatology to the COVID-19 Pandemic.

Murase JE, Murrell DF.

Performing dermoscopy in the COVID-19 pandemic.

Goldust M, Zalaudek I, Gupta A, Lallas A, Rudnicka L, Navarini AA.

Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?

Kutlu Ö, Metin A.

New emerging dermatological symptoms in coronavirus pandemic.

Gupta G, Singh Y, Kumar Chellappan D, Dua K.

Inpatient Teledermatology During the COVID-19 Pandemic.

Rismiller K, Cartron AM, Trinidad JCL.

The fate of major dermatology conferences and meetings of 2020; Are e-conferences and digital learning the future?

Bhargava S, Farabi B, Rathod D, Singh AK.

Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patients.

Pei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M.

Dupilumab and COVID-19: what should we expect?

Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M.

Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight.

Grandolfo M, Romita P, Bonamonte D, Cazzato G, Hansel K, Stingeni L, Conforti C, Giuffrida R, Foti C.

Hand disinfection in the combat against Covid-19.

Goldust M, Abdelmaksoud A, Navarini AA.

Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model.

Tejera-Vaquerizo A, Nagore E.

Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus.

Balestri R, Rech G, Girardelli CR.

Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.

Ehsani AH, Nasimi M, Bigdelo Z.

RAAS blockers in hypertension posing a higher risk towards the COVID-19.

Singh Y, Gupta G, Satija S, Negi P, Chellappan DK, Dua K.

Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy.

Tosti G, Barisani A, Queirolo P, Pennacchioli E, Villa L, Lodeserto AM, Vaccari S.

Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2).

Paolino G, Canti V, Raffaele Mercuri S, Rovere Querini P, Candiani M, Pasi F.

COVID-19 pandemic: University of Naples Federico II Dermatology's model of dermatology reorganization.

Patrì A, Gallo L, Annunziata MC, Megna M, Fabbrocini G.

Use of transparent curtains on bedside of COVID-19 patients.

Gupta S, Gupta S, Gujrathi AV.

Histological pattern in Covid-19 induced viral rash.

Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, Patrizi A, Gaspari V.

Cutaneous Sıde-Effects of the Potentıal Covıd-19 Drugs.

Türsen Ü, Türsen B, Lotti T.

Comment on "Antipsoriatic treatments during COVID-19 outbreak".

Abdelmaksoud A, Goldust M, Vestita M.

Itch in the era of COVID-19 pandemic: an unfolding scenario.

Stefaniak AA, Białynicki-Birula R, Krajewski P, Matusiak Ł, Goldust M, Szepietowski JC.

Biologic therapy for psoriasis during the COVID-19 outbreak: the choice is to weigh risks and benefits.

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I.

Systemic Isotretinoin Therapy In The Era Of COVID19.

Abdelmaksoud A, Vestita M, El-Amawy HS, Ayhan E, An İ, Öztürk M, Goldust M.

The use of Google trends for acral symptoms during COVID-19 outbreak in France.

Kluger N, Scrivener Y.

COVID-19 epidemic: Skin protection for health care workers must not be ignored.

Zhang B, Zhai R, Ma L.

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Balestri R, Rech G, Girardelli CR.

Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic.

Keeling E, Daly S, McKenna DB.

Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.

Torres-Navarro I, Abril-Pérez C, Roca-Ginés J, Sánchez-Arráez J, Botella-Estrada R, Évole-Buselli M.

Biologics increase the risk of SARS- CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration.

Damiani G, Pacifico A, Bragazzi NL, Malagoli P.

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.

The Dermatologist's Perspective: Why is COVID-19 mortality lower in females than males?

Murrell DF, Murase JE.

Cutaneous lesions in a patient with COVID-19: are they related?

Ahouach B, Harant S, Ullmer A, Martres P, Bégon E, Blum L, Tess O, Bachmeyer C.

Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Diaz-Guimaraens B, Dominguez-Santas M, Suarez-Valle A, Pindado-Ortega C, Selda-Enriquez G, Bea-Ardebol S, Fernandez-Nieto D.

Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Sanchez A, Sohier P, Benghanem S, L'Honneur AS, Rozenberg F, Dupin N, Garel B.

How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic.

Madigan LM, Micheletti RG, Shinkai K.

Urticarial exanthem as early diagnostic clue for COVID-19 infection.

Quintana-Castanedo L, Feito-Rodríguez M, Valero-López I, Chiloeches-Fernández C, Sendagorta-Cudós E, Herranz-Pinto P.

Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.

Mahil SK, Yiu ZZN, Mason KJ, Dand N, Coker B, Wall D, Fletcher G, Bosma A, Capon F, Iversen L, Langan SM, Di Meglio P, Musters A, Prieto-Merino D, Tsakok T, Warren RB, Flohr C, Spuls P, Griffiths CEM, Barker J, Irvine AD, Smith CH; et al.

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, et al.

The Danger of Neglecting Melanoma during the COVID-19 Pandemic.

Gomolin T, Cline A, Handler MZ.

The covid-19 outbreak in Italy: preventive and protective measures adopted by the dermatology unit of bologna university hospital.

Patrizi A, Bardazzi F, Filippi F, Abbenante D, Piraccini BM.

Which Dermatology Patients Attend to Dermatology Outpatient Clinics During the SARS-CoV-2 Outbreak in Turkey and What Happened to Them?

Cengiz FP, Emiroglu N, Bahali AG, Dizman D, Taslidere N, Akarslan TC, Gunes B, Mert O, Su Kucuk O, Onsun N.

Changing paradigms of dermatology practice in developing nations in the shadow of COVID-19: Lessons learnt from the pandemic.

Kumar S, Bishnoi A, Vinay K.

Frequent handwashing amidst the COVID-19 outbreak: prevention of hand irritant contact dermatitis and other considerations.

Abtahi-Naeini B.

Dermatologic findings in two patients with COVID-19.

Rivera-Oyola R, Koschitzky M, Printy R, Liu S, Stanger R, Golant A, Lebwohl M.

The impact of COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biologic therapy: the Northern Italy experience.

Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Malagoli P, Costanzo A.

Conducting Clinical Trials During the COVID-19 Pandemic.

Collier EK, Hsiao JL, Shi VY.

Chronic cutaneous ulcers management in dermatologic department during COVID-19 era.

Zagaria O, Ruggiero A, Cinelli E, Marasca C, Monfrecola A, Fabbrocini G.

Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019).

Morey-Olivé M, Espiau M, Mercadal-Hally M, Lera-Carballo E, García-Patos V.

No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.

Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.

Vascular skin symptoms in COVID-19: a french observational study.

Bouaziz JD, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, Arsouze A, Domergue Than Trong E, Bagot M, Begon E, Sulimovic L, Rybojad M.

Changes in emergency service access after spread of COVID19 across Italy.

Tartari F, Guglielmo A, Fuligni F, Pileri A.

Biologics for psoriasis in COVID-19 era: what do we know?

Megna M, Napolitano M, Patruno C, Fabbrocini G.

Teledermatology in the Wake of COVID-19: Advantages and Challenges to Continued Care in a Time of Disarray.

Gupta R, Ibraheim MK, Doan HQ.

Skin cancer triage and management during COVID-19 pandemic.

Tagliaferri L, Di Stefani A, Schinzari G, Fionda B, Rossi E, Del Regno L, Gentileschi S, Federico F, Valentini V, Tortora G, Peris K; Gemelli Skin-Cancer Multidisciplianry Tumour Board (S-MDTB)..

Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Kasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT.

Invited response to the comment on "Dermatology Residents and the Care of COVID-19 Patients".

Grant-Kels JM.

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment.

Gisondi P, Zaza G, Del Giglio M, Rossi M, Iacono V, Girolomoni G.

Comment on "Dermatology Residents and the Care of COVID-19 Patients".

Patel B.

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome.

Tammaro A, Adebanjo GAR, Parisella FR, Pezzuto A, Rello J.

Cutaneous manifestation of COVID-19 in images: A case report.

Avellana Moreno R, Villa E, Avellana Moreno V, Estela Villa C, Aparicio M, Fontanella A.

SARS-CoV-2 infection presenting as a febrile rash.

Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy-Marqueste C, Grob JJ, Raoult D, Brouqui P, Richard MA.

Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients.

Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, Berti S, Manunza F, Belloni Fortina A, Di Lernia V, Boccaletti V, De Bernardis G, Brunetti B, Mazzatenta C, Bassi A.

Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studies.

Garcovich S, Bersani FS, Chiricozzi A, De Simone C.

Acral cutaneous lesions in the Time of COVID-19.

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F.

Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.

Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.

Did Whatsapp(®) reveal a new cutaneous COVID-19 manifestation?

Duong TA, Velter C, Rybojad M, Comte C, Bagot M, Sulimovic L, Bouaziz JD.

Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection.

van Damme C, Berlingin E, Saussez S, Accaputo O.

Dermatoethics: Self-Prescribing Plaquenil during the COVID-19 Pandemic.

Stoj VJ, Grant-Kels JM.

HISTORICAL CORONA NAME IN DERMATOLOGY.

Türsen Ü, Türsen B, Lotti T.

Immunomodulators and immunosuppressants in the era of SARS-CoV-2 - could laboratory tests be the missing link?

Alpalh√£o M, Filipe P.

Alopecia areata not due by isotretinoin. A thought in COVID-19 time.

Rodríguez-Jiménez P, Ramirez-Bellver JL, Ruiz-Rodríguez R.

Management of advanced melanoma in the COVID-19 era.

Conforti C, Giuffrida R, Di Meo N, Zalaudek I.

Inpatient care for dermatological patients during SARS-CoV-2 - a case report from Portugal.

Alpalh√£o M, Filipe P.

Systemic Immunosuppressive Therapy for Inflammatory Skin Diseases in Children: Expert-Consensus-Based Guidance for Clinical Decision Making During the COVID-19 Pandemic.

Reynolds SD, Mathur AN, Chiu YE, Brandling-Bennett HA, Pope E, Siegel MP, Holland KE, Paller AS, Siegfried EC, Tom WL, Lara-Corrales I, Tollefson MM, Maguiness S, Eichenfield LF, Sugarman J, Frieden IJ, Oza VS, Cipriano SD, Huang JT, Shah SD, Lauren CT, Castelo-Soccio L, et al.

Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.

Gisondi P, Piaserico S, Conti A, Naldi L.

The role of occupational dermatology in the COVID-19 outbreak.

Patruno C, Fabbrocini G, Stingeni L, Napolitano M.

Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?

Genovese G, Colonna C, Marzano AV.

Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy.

Gianotti R, Veraldi S, Recalcati S, Cusini M, Ghislanzoni M, Boggio F, Fox LP.

Doxycycline, a widely used antibiotic in dermatology with a possible anti-inflammatory action against IL-6 in COVID-19 outbreak.

Conforti C, Giuffrida R, Zalaudek I, Di Meo N.

COVID-19 and psoriasis : should we fear for patients treated with biologics?

Amerio P, Prignano F, Giuliani F, Gualdi G.

Challenges of Covid-19 Pandemic for Dermatology.

Wollina U.

Comment on "Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S.

Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F, Masson Regnault M.

Response of a tertiary dermatology department to COVID-19.

Der Sarkissian S, Tjokrowidjaja A, Sebaratnam DF, Gupta M.

Morbilliform Exanthem Associated with COVID-19.

Najarian DJ.

Addressing the Question of Dermatologic Manifestations of SARS-CoV-2 Infection in the Lower Extremities: A Closer Look at the Available Data and its Implications.

Basatneh R, Vlahovic TC.

Coronavirus-Days in Dermatology.

Türsen Ü, Türsen B, Lotti T.

Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic.

Mugheddu C, Dell'Antonia M, Sanna S, Agosta D, Atzori L, Rongioletti F.

Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology.

Perkins S, Cohen JM, Nelson CA, Bunick CG.

Overzealous hand hygiene during COVID 19 pandemic causing increased incidence of hand eczema among general population.

Singh M, Pawar M, Bothra A, Choudhary N.

Letter from the Editors: Big Data and Cutaneous Manifestations of COVID-19.

Grant-Kels JM, Sloan B, Kantor J, Elston DM.

Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients.

Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, Veraldi S, Rubegni P, Cusini M, Caputo V, Rongioletti F, Berti E, Calzavara-Pinton P.

The AAD COVID-19 Registry: Crowdsourcing Dermatology in the Age of COVID-19.

Freeman EE, McMahon DE, Fitzgerald ME, Fox LP, Rosenbach M, Takeshita J, French LE, Thiers BH, Hruza GJ.

Telemedicine and support groups in order to improve the adherence to treatment and health related quality of life in patients affected by inflammatory skin conditions during COVID-19 emergency.

Marasca C, Ruggiero A, Fontanella G, Ferrillo M, Fabbrocini G, Villani A.

A novel clinical set up for examining healthy dermatology outpatients in time of Covid-19.

Gupta S, Jangra RS, Gujrathi AV, Mahendra A, Singla R, Sharma A, Gupta S.

Screen mirroring, screen casting and screen sharing during COVID-19: What a dermatologist should know.

Jakhar D, Kaur I, Kaul S.

Covid-19: Countermeasure for N95 mask-induced pressure sore.

Yin Z.

Skin Reactions to Non-glove Personal Protective Equipment: An Emerging Issue in the COVID-19 Pandemic.

Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S.

Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?

Di Altobrando A, Patrizi A, Bardazzi F.

A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East.

Alramthan A, Aldaraji W.

Phototherapeutic approach to dermatological patients during the 2019 Coronavirus pandemic: Real-life Data from the Italian Red Zone.

Pacifico A, Ardigò M, Frascione P, Damiani G, Morrone A.

Secure communication conduits during COVID19 lockdown.

Black SM, Ali FR.

Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.

Megna M, Ruggiero A, Marasca C, Fabbrocini G.

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Management of Infantile Hemangiomas during the COVID Pandemic.

Frieden IJ, Püttgen KB, Drolet BA, Garzon MC, Chamlin SL, Pope E, Mancini AJ, Lauren CT, Mathes EF, Siegel DH, Gupta D, Haggstrom AN, Tollefson MM, Baselga E, Morel KD, Shah SD, Holland KE, Adams DM, Horii KA, Newell BD, Powell J, McCuaig CC, et al.

EMPLOYING DERMATOLOGISTS ON THE FRONTLINE AGAINST COVID-19: ALL HANDS ON DECK.

Bhargava S, Rokde R, Rathod D, Kroumpouzos G.

CORONAVIRUS-DAYS IN DERMATOLOGY.

TüRsen Ü, Türsen B, Lotti T.

Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.

Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W.

Face the COVID-19 emergency: measures applied in an Italian Dermatologic Clinic.

Marasca C, Ruggiero A, Annunziata MC, Fabbrocini G, Megna M.

Urticarial eruption in COVID-19 infection.

Henry D, Ackerman M, Sancelme E, Finon A, Esteve E.

COVID-19 and Cutaneous manifestations.

Mungmungpuntipantip R, Wiwanitkit V.

Viral exanthem in COVID-19, a clinical enigma with biological significance.

Su CJ, Lee CH.

Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy).

Atzori L, Mugheddu C, Addis G, Sanna S, Satta R, Ferreli C, Atzori MG, Montesu MA, Rongioletti F.

Cutaneous manifestations in COVID-19: a new contribution.

Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD.

Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.

Fernandez-Nieto D, Ortega-Quijano D, Segurado-Miravalles G, Pindado-Ortega C, Prieto-Barrios M, Jimenez-Cauhe J.

A distinctive skin rash associated with Coronavirus Disease 2019 ?

Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L.

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.

Messina F, Piaserico S.

Psoriasis and Psoriatic Arthritis: how to manage Immunosuppressants in COVID-19‚Äâdays.

Coletto LA, Favalli EG, Caporali R.

Treatment considerations for patients with pemphigus during the COVID-19 pandemic.

Shakshouk H, Daneshpazhooh M, Murrell DF, Lehman JS.

Recommendations on dermatologic surgery during the COVID-19 pandemic.

Der Sarkissian SA, Kim L, Veness M, Yiasemides E, Sebaratnam DF.

Optimizing Teledermatology Visits for Dermatology Resident Education During the COVID-19 Pandemic.

Oldenburg R, Marsch A.

Various forms of skin rash in COVID-19 : a reply.

Joob B, Wiwanitkit V.

Biologics for psoriasis during COVID-19 outbreak.

Di Lernia V.

COVID-19 can present with a rash and be mistaken for Dengue

: Petechial rash in a patient with COVID-19 infection.

A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis.

Manalo IF, Smith MK, Cheeley J, Jacobs R.

A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom.

Hunt M, Koziatek C.

The management of biologics in dermatologic patients in the 2019-nCoV era.

Plachouri KM, Georgiou S.

Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease.

Freeman EE, McMahon DE.

Challenges and issues about organising a hospital to respond to the COVID-19 outbreak: experience from a French reference centre.

Peiffer-Smadja N, Lucet JC, Bendjelloul G, Bouadma L, Gerard S, Choquet C, Jacques S, Khalil A, Maisani P, Casalino E, Descamps D, Timsit JF, Yazdanpanah Y, Lescure FX.

Strategic Dermatology Clinical Operations During COVID-19 Pandemic.

Price KN, Thiede R, Shi VY, Curiel-Lewandrowski C.

COVID-19 and SARS: differences and similarities.

Antonio C, Claudio C, Nicola DM, Caterina D, Jafferany M, Lotti T, Zalaudek I, Giuffrida R.

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.

Torres T, Puig L.

The Effect of Quarantine and Isolation for COVID-19 in General Population and Dermatologic Treatments.

Sharma A, Fölster-Holst R, Kassir M, Szepietowski J, Jafferany M, Lotti T, Goldust M.

COVID-19: A Relationship to Climate and Environmental Conditions?

Kroumpouzos G, Gupta M, Jafferany M, Lotti T, Sadoughifar R, Sitkowska Z, Goldust M.

SECURE-Psoriasis: a de-identified registry of psoriasis patients diagnosed with COVID-19.

Balogh EA, Heron C, Feldman SR, Huang WW.

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Kutlu Ö, Metin A.

Dermatology Residents and the Care of COVID-19 Patients.

Stoj VJ, Grant-Kels JM.

COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australia/New Zealand consensus statement.

Wang C, Rademaker M, Baker C, Foley P.

Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity.

Shanshal M.

Adverse Skin Reactions Among Healthcare Workers During the Coronavirus Disease 2019 Outbreak: A Survey in Wuhan and Its Surrounding Regions.

Lin P, Zhu S, Huang Y, Li L, Tao J, Lei T, Song J, Liu D, Chen L, Shi Y, Jiang S, Liu Q, Xie J, Chen H, Duan Y, Xia Y, Zhou Y, Mei Y, Zhou X, Wu J, Fang M, Meng Z, et al.

Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.

Schwartz RA, Janniger CK.

Biologic therapy for psoriasis during the covid-19 outbreak is not a choice.

Bardazzi F, Loi C, Sacchelli L, Di Altobrando A.

WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.

Deepak J, Subuhi K, Ishmeet K.

COVID-19: Challenges and opportunities for dermatology response.

Chawla S.

Coronavirus disease 2019 (COVID-19): facts and controversies.

Conforti C, Cannavò SP, Jafferany M, Dianzani C, Meo ND, Lotti T, Zalaudek I, Giuffrida R.

Comment on "COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action".

.

Priorities for global health community in COVID-19 pandemic.

Rudnicka L, Gupta M, Kassir M, Jafferany M, Lotti T, Sadoughifar R, Goldust M.

Teledermatology: a useful tool to fight COVID-19.

Villani A, Scalvenzi M, Fabbrocini G.

An assessment of United States dermatology practices during the COVID-19 outbreak.

Muddasani S, Housholder A, Fleischer AB.

The COVID-19 outbreak and rheumatologic skin diseases.

Arora G, Kassir M, Jafferany M, Galadari H, Lotti T, Satolli F, Sadoughifar R, Sitkowska Z, Goldust M.

What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy.

Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T.

Solidarity and transparency against the COVID-19 pandemic.

Arora G, Kroumpouzos G, Kassir M, Jafferany M, Lotti T, Sadoughifar R, Sitkowska Z, Grabbe S, Goldust M.

COVID-19 and Immunomodulator/Immunosuppressant Use in Dermatology.

Price KN, Frew JW, Hsiao JL, Shi VY.

Ethical Outpatient Dermatology Care During the Coronavirus (COVID-19) Pandemic.

Pathoulas JT, Stoff BK, Lee KC, Farah RS.

Biological treatment during COVID-19 outbreak.

Sriwijitalai W, Wiwanitkit V.

Antipsoriatic treatments during COVID-19 outbreak.

Di Lernia V.

Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day!

Jakhar D, Kaur I, Kaul S.

European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis.

Wollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson √Ö, Hijnen D, Gelmetti C, Szalai Z, et al.

COVID-19 in the pediatric population.

Abdelmaksoud A, Kroumpouzos G, Jafferany M, Lotti T, Sadoughifar R, Goldust M.

What dermatologists could do to cope with the novel coronavirus (SARS-CoV-2): a dermatologist's perspective from China.

Zhang H, Tang K, Fang R, Sun Q.

Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chances.

Reinholz M, French LE.

Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.

Rademaker M, Baker C, Foley P, Sullivan J, Wang C.

COVID-19 and economy.

Gupta M, Abdelmaksoud A, Jafferany M, Lotti T, Sadoughifar R, Goldust M.

Cutaneous manifestations in COVID-19: a first perspective.

Recalcati S.

Dermatology practices as vectors for COVID-19 transmission: a call for immediate cessation of non-emergent dermatology visits.

Kwatra SG, Sweren RJ, Grossberg AL.

Dermatology staff participate in fight against Covid-19 in China.

Zheng Y, Lai W.

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.

Radi G, Diotallevi F, Campanati A, Offidani A.

Should patients stop their biologic treatment during the COVID-19 pandemic.

Bashyam AM, Feldman SR.

Skin damage among healthcare workers managing coronavirus disease-2019.

Lan J, Song Z, Miao X, Li H, Li Y, Dong L, Yang J, An X, Zhang Y, Yang L, Zhou N, Yang L, Li J, Cao J, Wang J, Tao J.

Letter from the Editor: Occupational skin disease among healthcare workers during the Coronavirus (COVID-19) epidemic.

Elston DM.

Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019.

Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L, Gao X, Gu H, He L, Ji C, Jin H, Lai W, Lei T, Li L, Li L, Li R, Liu D, Liu W, Lu Q, Shi Y, Song J, Tao J, et al.

COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.

Conforti C, Giuffrida R, Dianzani C, Di Meo N, Zalaudek I.

Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.

Tao J, Song Z, Yang L, Huang C, Feng A, Man X.